Overview of the RGD-Based PET Agents Use in Patients With Cardiovascular Diseases: A Systematic Review

Overview of the RGD-Based PET Agents Use in Patients With Cardiovascular Diseases: A Systematic Review

Studies using arginine–glycine–aspartate (RGD)-PET agents in cardiovascular diseases have been recently published. The aim of this systematic review was to perform an updated, evidence-based summary about the role of RGD-based PET agents in patients with cardiovascular diseases to better address fut...

Full description

Bibliographic Details
Main Authors: Matthieu Dietz, Christel H. Kamani, Vincent Dunet, Stephane Fournier, Vladimir Rubimbura, Nathalie Testart Dardel, Ana Schaefer, Mario Jreige, Sarah Boughdad, Marie Nicod Lalonde, Niklaus Schaefer, Nathan Mewton, John O. Prior, Giorgio Treglia
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Medicine
Subjects:
αvβ3 integrin
RGD
angiogenesis
positron emission tomography
cardiovascular diseases
myocardial infarction
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.887508/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.887508/full

Similar Items